Orange Book product · Brand (NDA)
CARDIZEM CD
DILTIAZEM HYDROCHLORIDE
At a glance
Dec 27, 1991
Approved
Brand (NDA)
Application
AB3
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 27, 1991
35 yr ago
Today
Pharmaceutical detail
Active ingredient
DILTIAZEM HYDROCHLORIDE
Strength
300MG
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
TE code
AB3
Application
NDA 020062
Product number
004
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2000DILTIAZEM HYDROCHLORIDEBrand (NDA)
NDA 020939 · BIOVAIL
- 1997CARDIZEMBrand (NDA)
NDA 020792 · BIOVAIL
- 1995TIAZACBrand (NDA)
NDA 020401 · BAUSCH
- 1992DILACOR XRBrand (NDA)
NDA 020092 · ALLERGAN
- 1991CARDIZEMBrand (NDA)
NDA 020027 · BIOVAIL LABS INTL
- 1989CARDIZEM SRBrand (NDA)
NDA 019471 · BIOVAIL
- 2026DILTIAZEM HYDROCHLORIDEGeneric (ANDA)
ANDA 218744 · MACLEODS PHARMS LTD
- 2025DILTIAZEM HYDROCHLORIDEGeneric (ANDA)
ANDA 218032 · NOVAST LABS
- 2025DILTIAZEM HYDROCHLORIDEGeneric (ANDA)
ANDA 219073 · UTOPIC PHARMS
- 2024DILTIAZEM HYDROCHLORIDEGeneric (ANDA)
ANDA 216968 · ALEMBIC
- 2024DILTIAZEM HYDROCHLORIDEGeneric (ANDA)
ANDA 218587 · ALEMBIC
- 2023DILTIAZEM HYDROCHLORIDEGeneric (ANDA)
ANDA 216552 · EUGIA PHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
